Trial Profile
Cognitive Function in Healthy Volunteers Exposed to Acute Pain Before and After Administration of Remifentanil.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Pain
- Focus Pharmacodynamics
- Acronyms Kogprem
- 13 Feb 2012 Actual patient number (23) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jun 2011 New trial record